DIKI REYES: Open Payments
NPI 1528263621 · PLEASANTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 10 payments from 6 companies in 2025. Trend: 2023 $236 · 2024 $267 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 2 | $126 |
| Amgen Inc. | 3 | $62 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $28 |
| Novo Nordisk Inc | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: XYOSTED, OTEZLA, Qelbree, UBRELVY, Ozempic, FARXIGA.
Industry payments across TX — which companies pay providers there.
